Half-year report · HY
7701.TEDINET S100WZW7
Period2025-04-01 → 2025-09-30
Filed2025-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥256.3bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥539.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥251.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥31.6bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥30.2bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥31.3bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥72.0bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥28.4bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥31.4bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥28.4bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥23.6bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥53.8bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥21.3bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥23.6bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥21.3bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥672.5bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥672.2bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥650.3bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥158.5bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥174.1bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥514.0bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥498.1bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥490.5bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥152.2bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥143.4bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥147.2bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥137.2bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥152.0bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥159.2bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥30.4bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥52.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥28.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥8.2bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥23.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥14.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥14.3bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥48.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥16.4bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥81.79 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥183.55 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥72.38 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 76.4% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.1% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.4% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2025-09-30 | ¥4.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥3.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥1.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2025-09-30 | ¥455m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥1.2bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥1.2bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥1.7bn |
| Aircraft Equipmentreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥18.2bn |
| Aircraft Equipmentreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥18.2bn |
| Aircraft Equipmentreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥8m |
| Aircraft Equipmentreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥3.6bn |
| Analytical And Measuring Instrumentsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥168.2bn |
| Analytical And Measuring Instrumentsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥168.1bn |
| Analytical And Measuring Instrumentsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥20m |
| Analytical And Measuring Instrumentsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥23.4bn |
| Industrial Machineryreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥32.9bn |
| Industrial Machineryreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥32.9bn |
| Industrial Machineryreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥30m |
| Industrial Machineryreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥4.6bn |
| Medical Systemsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥33.6bn |
| Medical Systemsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥33.6bn |
| Medical Systemsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥12m |
| Medical Systemsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥1.3bn |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥253.0bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥252.9bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥72m |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥32.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥257.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥256.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥33.3bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥3.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥2.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥1.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥153m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥1.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥1.3bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥519m |
| Aircraft Equipmentreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥18.0bn |
| Aircraft Equipmentreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥18.0bn |
| Aircraft Equipmentreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥18m |
| Aircraft Equipmentreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥2.4bn |
| Analytical And Measuring Instrumentsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥160.6bn |
| Analytical And Measuring Instrumentsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥160.6bn |
| Analytical And Measuring Instrumentsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥19m |
| Analytical And Measuring Instrumentsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥21.3bn |
| Industrial Machineryreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥36.1bn |
| Industrial Machineryreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥36.0bn |
| Industrial Machineryreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥34m |
| Industrial Machineryreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥5.3bn |
| Medical Systemsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥34.0bn |
| Medical Systemsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥34.0bn |
| Medical Systemsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥7m |
| Medical Systemsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥1.6bn |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥248.8bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥248.7bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥80m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥30.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥252.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥251.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥30.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 560
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes regarding dividend (text) | InterimDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | InterimDuration | Text · Plus | |
| Notes segment information etc type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | InterimDuration | Text · Plus | |
| Notes revenue recognition semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes per share information semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes significant events after reporting period semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | InterimDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |